These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
278 related items for PubMed ID: 16930249
41. [Promote allergen specific immunotherapy actively]. Zhang L, Han DM. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Dec; 46(12):969-71. PubMed ID: 22336005 [No Abstract] [Full Text] [Related]
46. [Allergens for specific immunotherapy: authorization and quality criteria of the Paul-Ehrlich-Institut]. May S, Kaul S, Schröder C, Vieths S. Hautarzt; 2006 Oct 21; 57(10):867-74. PubMed ID: 16977441 [Abstract] [Full Text] [Related]
47. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C. J Allergy Clin Immunol; 2007 Sep 21; 120(3):707-13. PubMed ID: 17681368 [Abstract] [Full Text] [Related]
48. Update on mechanisms of allergen injection immunotherapy. James LK, Durham SR. Clin Exp Allergy; 2008 Jul 21; 38(7):1074-88. PubMed ID: 18691292 [Abstract] [Full Text] [Related]
50. Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy. Di Lorenzo G, Mansueto P, Pacor ML, Rizzo M, Castello F, Martinelli N, Ditta V, Lo Bianco C, Leto-Barone MS, D'Alcamo A, Di Fede G, Rini GB, Ditto AM. J Allergy Clin Immunol; 2009 May 21; 123(5):1103-10, 1110.e1-4. PubMed ID: 19356792 [Abstract] [Full Text] [Related]
51. Mechanisms of allergen-specific immunotherapy. Akdis M, Akdis CA. J Allergy Clin Immunol; 2007 Apr 21; 119(4):780-91. PubMed ID: 17321578 [Abstract] [Full Text] [Related]
55. Instructions and consent forms for subcutaneous allergen immunotherapy. Cox L, Lockey RF. Clin Allergy Immunol; 2008 Aug 21; 21():499-525. PubMed ID: 18828526 [No Abstract] [Full Text] [Related]
56. Administration regimens for sublingual immunotherapy to pollen allergens: what do we know? Lombardi C, Incorvaia C, Braga M, Senna G, Canonica GW, Passalacqua G. Allergy; 2009 Jun 21; 64(6):849-54. PubMed ID: 19392995 [Abstract] [Full Text] [Related]
57. Recombinant and modified allergens: the U.S. perspective. Rabin RL. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006 Jun 21; (95):191-3; discussion 193-4. PubMed ID: 17393739 [Abstract] [Full Text] [Related]
58. Epicutaneous allergen administration: a novel approach for allergen-specific immunotherapy? Werfel T. J Allergy Clin Immunol; 2009 Nov 21; 124(5):1003-4. PubMed ID: 19895988 [No Abstract] [Full Text] [Related]
59. The GILL study: glycerin-induced local reactions in immunotherapy. Calabria CW, Coop CA, Tankersley MS. J Allergy Clin Immunol; 2008 Jan 21; 121(1):222-6. PubMed ID: 17919703 [Abstract] [Full Text] [Related]